1887

6 : West Nile Virus

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

West Nile Virus, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815585/9781555813772_Chap06-1.gif /docserver/preview/fulltext/10.1128/9781555815585/9781555813772_Chap06-2.gif

Abstract:

This chapter highlights many aspects of the West Nile virus (WNV) that is an emerging pathogen, including its epidemiology in the Americas, new clinical syndromes, new modes of transmission and their impacts on public health, and progress in the development of therapeutics and vaccines. Virology, entomology, ecology, and pathogenesis are discussed only to the extent required to provide background for the main topics. Strains of WNV can be divided into two genetic lineages by phylogenetic analysis of the complete genome sequence or of the E protein gene sequence. The major mosquito vector in Africa and the Middle East is , with , , , , or spp. important in some areas. Further evidence that WNV could produce severe neurological disease was obtained in the early 1950s during experiments with WNV as an experimental cancer therapy. Advanced age is the most important risk factor for death. Surveillance data indicate that case fatality rates for persons with WNV neuroinvasive disease increase from 1% among persons under 40 years of age to 36% among persons 90 years old and older. Reduction of vector populations by public mosquito control programs is another mainstay of WNV prevention in North America. New clinical syndromes and new modes of transmission were identified, including transmission by transfused blood. This led to universal WNV screening of donated blood in the United States and Canada.

Citation: Petersen L. 2007. West Nile Virus, p 99-119. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch6
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1.
Figure 1.

Known geographic distribution of the JEV serogroup viruses of medical importance before 1999. The distribution of WNV in the United States from 1999 through 2005 is shown in Color Plate 2.

Citation: Petersen L. 2007. West Nile Virus, p 99-119. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch6
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2.
Figure 2.

WNV transmission cycle. In North America, and are the main maintenance and amplification vectors. and some mosquitoes of the genera and may be important vectors to humans in some areas.

Citation: Petersen L. 2007. West Nile Virus, p 99-119. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch6
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3.
Figure 3.

Numbers of reported cases of WNV neuroinvasive disease by week of symptom onset, 2002 to 2004.

Citation: Petersen L. 2007. West Nile Virus, p 99-119. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch6
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815585.ch06
1. Adelman, R. A.,, J. H. Membreno,, N. A. Afshari, and, K. M. Stoessel. 2003. West Nile virus chorioretinitis. Retina 23:100101.
2. Agrawal, A. G., and, L. R. Petersen. 2003. Human immunoglobulin as a treatment for West Nile virus infection. J. Infect. Dis. 188:14.
3. Ahmed, S.,, R. Libman,, K. Wesson,, F. Ahmed, and, K. Einberg. 2000. Guillain-Barre syndrome: an unusual presentation of West Nile virus infection. Neurology 55:144146.
4. Almhanna, K.,, N. Palanichamy,, M. Sharma,, R. Hobbs, and, A. Sil. 2003. Unilateral brachial plexopathy associated with West Nile virus meningoencephalitis. Clin. Infect. Dis. 36:16291630.
5. Anderson, J. F., and, J. J. Rahal. 2002. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg. Infect. Dis. 8:107108.
6. Anderson, R. C.,, K. B. Horn,, M. P. Hoang,, E. Gottlieb, and, B. Bennin. 2004. Punctate exanthem of West Nile Virus infection: report of 3 cases. J. Am. Acad. Dermatol. 51:820823.
7. Andis, M. D.,, S. R. Sackett,, M. K. Carroll, and, E. S. Bordes. 1987. Strategies for the emergency control of arboviral epidemics in New Orleans. J. Am. Mosq. Control. Assoc. 3:125130.
8. Arroyo, J.,, C. Miller,, J. Catalan,, G. A. Myers,, M. S. Ratterree,, D. W. Trent, and, T. P. Monath. 2004. ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J. Virol. 78:1249712507.
9. Barnard, D. R., and, R. Xue. 2004. Laboratory evaluation of mosquito repellents against Aedes albopictus, Culex nigripalpus, and Ochelerotatus triseriatus (Diptera: Culicidae). J. Med. Entomol. 41:726730.
10. Beasley, D. W.,, C. T. Davis,, H. Guzman,, D. L. Vanlandingham,, A. P. Travassos da Rosa,, R. E. Parsons,, S. Higgs,, R. B. Tesh, and, A. D. Barrett. 2003. Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology 309:190195.
11. Ben-Nathan, D.,, S. Lustig,, G. Tam,, S. Robinzon,, S. Segal, and, B. Rager-Zisman. 2003. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J. Infect. Dis. 188:512.
12. Betensley, A. D.,, S. H. Jaffery,, H. Collins,, N. Sripathi, and, F. Alabi. 2004. Bilateral diaphragmatic paralysis and related respiratory complications in a patient with West Nile virus infection. Thorax 59:268269.
13. Biggerstaff, B. J., and, L. R. Petersen. 2002. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 42:10191026.
14. Biggerstaff, B. J., and, L. R. Petersen. 2003. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 43:10071017.
15. Blitvich, B. J.,, I. Fernandez-Salas,, J. F. Contreras-Cordero,, N. L. Marlenee,, J. I. Gonzalez-Rojas,, N. Komar,, D. J. Gubler,, C. H. Calisher, and, B. J. Beaty. 2003. Serologic evidence of West Nile virus infection in horses, Coahuila State, Mexico. Emerg. Infect. Dis. 9:853856.
16. Blitvich, B. J.,, I. Fernandez-Salas,, J. F. Contreras-Cordero,, M. A. Lorono-Pino,, N. L. Marlenee,, F. J. Diaz,, J. I. Gonzalez-Rojas,, N. Obregon-Martinez,, J. A. Chiu-Garcia,, W. C. T. Black, and, B. J. Beaty. 2004. Phylogenetic analysis of West Nile virus, Nuevo Leon State, Mexico. Emerg. Infect. Dis. 10:13141317.
17. Bosanko, C. M.,, J. Gilroy,, A. M. Wang,, W. Sanders,, M. Dulai,, J. Wilson, and, K. Blum. 2003. West Nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch. Neurol. 60:14481452.
18. Brault, A. C.,, S. A. Langevin,, R. A. Bowen,, N. A. Panella,, B. J. Biggerstaff,, B. R. Miller, and, N. Komar. 2004. Differential virulence of West Nile strains for American crows. Emerg. Infect. Dis. 10:21612168.
19. Buescher, M. D.,, L. C. Rutledge,, R. A. Wirtz, and, J. H. Nelson. 1983. The dose-persistence relationship of DEET against Aedes aegypti. Mosq. News 43:364366.
20. Burton, J. M.,, R. Z. Kern,, W. Halliday,, D. Mikulis,, J. Brunton,, M. Fearon,, C. Pepperell, and, C. Jaigobin. 2004. Neurological manifestations of West Nile virus infection. Can. J. Neurol. Sci. 31:185193.
21. Busch, M. P.,, S. Caglioti,, E. F. Robertson,, J. D. McAuley,, L. H. Tobler,, H. Kamel,, J. M. Linnen,, V. Shyamala,, P. Tomasulo, and, S. H. Kleinman. 2005. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N. Engl. J. Med. 353:460467.
22. Busch, M. P.,, L. H. Tobler,, J. Saldanha,, S. Caglioti,, V. Shyamala,, J. M. Linnen,, J. Gallarda,, B. Phelps,, R. I. Smith,, M. Drebot, and, S. H. Kleinman. 2005. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion 45:492499.
23. Camenga, D. L.,, N. Nathanson, and, G. A. Cole. 1974. Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J. Infect. Dis. 130:634641.
24. Cao, N. J.,, C. Ranganathan,, W. J. Kupsky, and, J. Li. 2005. Recovery and prognosticators of paralysis in West Nile virus infection. J. Neurol. Sci. 236:7380.
25. Centers for Disease Control and Prevention. 2000. Update: West Nile virus activity— Eastern United States, 2000. Morb. Mortal. Wkly. Rep. 49:10441047.
26. Centers for Disease Control and Prevention. 2001. Serosurveys for West Nile virus infection—New York and Connecticut counties, 2000. Morb. Mortal. Wkly. Rep. 50:3739.
27. Centers for Disease Control and Prevention. 2002. Possible West Nile virus transmission to an infant through breast-feeding—Michigan, 2002. Morb. Mortal. Wkly. Rep. 51:877878.
28. Centers for Disease Control and Prevention. 2002. Laboratory-acquired West Nile virus infections— United States, 2002. Morb. Mortal. Wkly. Rep. 51:11331135.
29. Centers for Disease Control and Prevention. 2002. West Nile Virus activity—United States, 2001. Morb. Mortal. Wkly. Rep. 51:497501.
30. Centers for Disease Control and Prevention. 2003. West Nile virus infection among turkey breeder farm workers—Wisconsin, 2002. Morb. Mortal. Wkly. Rep. 52:10171019.
31. Centers for Disease Control and Prevention. 2003. Surveillance for acute insecticide-related illness associated with mosquito-control efforts—nine states, 1999–2002. Morb. Mortal. Wkly. Rep. 52:629634.
32. Centers for Disease Control and Prevention. 2004. Possible dialysis-related West Nile virus transmission—Georgia, 2003. Morb. Mortal. Wkly. Rep. 53:738739.
33. Centers for Disease Control and Prevention. 2004. Transfusion-associated transmission of West Nile virus—Arizona, 2004. Morb. Mortal. Wkly. Rep. 53:842844.
34. Centers for Disease Control and Prevention. 2004. Update: West Nile virus screening of blood donations and transfusion-associated transmission—United States, 2003. Morb. Mortal. Wkly. Rep. 53:281284.
35. Centers for Disease Control and Prevention. 2005. Human exposure to mosquito-control pesticides— Mississippi, North Carolina, and Virginia, 2002 and 2003. Morb. Mortal. Wkly. Rep. 54:529532.
36. Centers for Disease Control and Prevention. 2005. West Nile virus infections in organ transplant recipients—New York and Pennsylvania, August-September, 2005. Morb. Mortal. Wkly. Rep. 54:10211023.
37. Chowers, M. Y.,, R. Lang,, F. Nassar,, D. Ben-David,, M. Giladi,, E. Rubinshtein,, A. Itzhaki,, J. Mishal,, Y. Siegman-Igra,, R. Kitzes,, N. Pick,, Z. Landau,, D. Wolf,, H. Bin,, E. Mendelson,, S. D. Pitlik, and, M. Weinberger. 2001. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg. Infect. Dis. 7:675678.
38. Costantini, C.,, A. Badolo, and, E. Ilboudo-Sanogo. 2004. Field evaluation of the efficacy and persistence of insect repellents DEET, IR3535, and KBR 3023 against Anopheles gambiae complex and other Afrotropical vector mosquitoes. Trans. R. Soc. Trop. Med. Hyg. 98:644652.
39. Creech, W. B., 1977. St. Louis encephalitis in the United States, 1975. J. Infect. Dis. 135:10141016.
40. Cruz, L.,, V. M. Cardenas,, M. Abarca,, T. Rodriguez,, R. F. Reyna,, M. V. Serpas,, R. E. Fontaine,, D. W. Beasley,, A. P. Da Rosa,, S. C. Weaver,, R. B. Tesh,, A. M. Powers, and, G. Suarez-Rangel. 2005. Short report: serological evidence of West Nile virus activity in El Salvador. Am. J. Trop. Med. Hyg. 72:612615.
41. Custer, B.,, P. A. Tomasulo,, E. L. Murphy,, S. Caglioti,, D. Harpool,, P. McEvoy, and, M. P. Busch. 2004. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion 44:15471554.
42. Davis, B. S.,, G. J. Chang,, B. Cropp,, J. T. Roehrig,, D. A. Martin,, C. J. Mitchell,, R. Bowen, and, M. L. Bunning. 2001. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75:40404047.
43. Davis, C. T.,, D. W. Beasley,, H. Guzman,, R. Raj,, M. D’Anton,, R. J. Novak,, T. R. Unnasch,, R. B. Tesh, and, A. D. Barrett. 2003. Genetic variation among temporally and geographically distinct West Nile virus isolates, United States, 2001, 2002. Emerg. Infect. Dis. 9:14231429.
44. Davis, C. T.,, D. W. Beasley,, H. Guzman,, M. Siirin,, R. Parsons,, R. Tesh, and, A. D. Barrett. 2004. Emergence of attenuated West Nile virus variants in Texas. Virology 330:342350.
45. Davis, C. T.,, G. D. Ebel,, R. S. Lanciotti,, A. C. Brault,, H. Guzman,, M. Siirin,, A. Lambert,, R. E. Parsons,, D. W. Beasley,, R. J. Novak,, D. Elizondo-Quiroga,, E. N. Green,, D. S. Young,, L. M. Stark,, M. A. Drebot,, H. Artsob,, R. B. Tesh,, L. D. Kramer, and, A. D. Barrett. 2005. Phylogenetic analysis of North American West Nile virus isolates, 2001–2004: evidence for the emergence of a dominant genotype. Virology 342:252265.
46. Depoortere, E.,, J. Kavle,, K. Keus,, H. Zeller,, S. Murri, and, D. Legros. 2004. Outbreak of West Nile virus causing severe neurological involvement in children, Nuba Mountains, Sudan, 2002. Trop. Med. Int. Health 9:730736.
47. Diamond, M. S.,, E. M. Sitati,, L. D. Friend,, S. Higgs,, B. Shrestha, and, M. Engle. 2003. A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198:18531862.
48. Doron, S. I.,, J. F. Dashe,, L. S. Adelman,, W. F. Brown,, B. G. Werner, and, S. Hadley. 2003. Histopathologically proven poliomyelitis with quadriplegia and loss of brainstem function due to West Nile virus infection. Clin. Infect. Dis. 37:e74e77. [Online.]
49. Dupuis, A. P., II,, P. P. Marra, and, L. D. Kramer. 2003. Serologic evidence of West Nile virus transmission, Jamaica, West Indies. Emerg. Infect. Dis. 9:860863.
50. Dupuis, A. P., II,, P. P. Marra,, R. Reitsma,, M. J. Jones,, K. L. Louie, and, L. D. Kramer. 2005. Serologic evidence for West Nile virus transmission in Puerto Rico and Cuba. Am. J. Trop. Med. Hyg. 73:474476.
51. Ebel, G. D.,, J. Carricaburu,, D. Young,, K. A. Bernard, and, L. D. Kramer. 2004. Genetic and phenotypic variation of West Nile virus in New York, 2000–2003. Am. J. Trop. Med. Hyg. 71:493500.
52. Emig, M., and, D. J. Apple. 2004. Severe West Nile virus disease in healthy adults. Clin. Infect. Dis. 38:289292.
53. Estrada-Franco, J. G.,, R. Navarro-Lopez,, D. W. Beasley,, L. Coffey,, A. S. Carrara,, A. Travassos da Rosa,, T. Clements,, E. Wang,, G. V. Ludwig,, A. C. Cortes,, P. P. Ramirez,, R. B. Tesh,, A. D. Barrett, and, S. C. Weaver. 2003. West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg. Infect. Dis. 9:16041607.
54. Fan, E.,, D. M. Needham,, J. Brunton,, R. Z. Kern, and, T. E. Stewart. 2004. West Nile virus infection in the intensive care unit: a case series and literature review. Can. Respir. J. 11:354358.
55. Ferguson, D. D.,, K. Gershman,, A. LeBailly, and, L. R. Petersen. 2005. Characteristics of the rash associated with West Nile virus fever. Clin. Infect. Dis. 41:12041207.
56. Fernandez-Salas, I.,, J. F. Contreras-Cordero,, B. J. Blitvich,, J. I. Gonzalez-Rojas,, A. Cavazos-Alvarez,, N. L. Marlenee,, A. Elizondo-Quiroga,, M. A. Lorono-Pino,, D. J. Gubler,, B. C. Cropp,, C. H. Calisher, and, B. J. Beaty. 2003. Serologic evidence of West Nile Virus infection in birds, Tamaulipas State, Mexico. Vector Borne Zoonotic Dis. 3:209213.
57. Fonseca, K.,, G. D. Prince,, J. Bratvold,, J. D. Fox,, M. Pybus,, J. K. Preksaitis, and, P. Tilley. 2005. West Nile virus infection and conjunctival exposure. Emerg. Infect. Dis. 11:16481649.
58. Fradin, M. S., 1998. Mosquitoes and mosquito repellents: a clinician’s guide. Ann. Intern. Med. 128:931940.
59. Frances, S. P.,, N. Van Dung,, N. W. Beebe, and, M. Debboun. 2002. Field evaluation of repellent formulations against daytime and nighttime biting mosquitoes in a tropical rainforest in northern Australia. J. Med. Entomol. 39:541544.
60. Frances, S. P.,, D. G. Waterson,, N. W. Beebe, and, R. D. Cooper. 2004. Field evaluation of repellent formulations containing DEET and picaridin against mosquitoes in Northern Territory, Australia. J. Med. Entomol. 41:414417.
61. Garg, S., and, L. M. Jampol. 2005. Systemic and intraocular manifestations of West Nile virus infection. Surv. Ophthalmol. 50:313.
62. Goldblum, N.,, V. V. Sterk, and, B. Paderski. 1954. West Nile fever; the clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases. Am. J. Hyg. 59:89103.
63. Granwehr, B. P.,, L. Li,, C. T. Davis,, D. W. Beasley, and, A. D. Barrett. 2004. Characterization of a West Nile virus isolate from a human on the Gulf Coast of Texas. J. Clin. Microbiol. 42:53755377.
64. Green, M. S.,, M. Weinberger,, J. Ben-Ezer,, H. Bin,, E. Mendelson,, D. Gandacu,, Z. Kaufman,, R. Dichtiar,, A. Sobel,, D. Cohen, and, M. Y. Chowers. 2005. Long-term death rates, West Nile virus epidemic, Israel, 2000. Emerg. Infect. Dis. 11:17541757.
65. Guarner, J.,, W. J. Shieh,, S. Hunter,, C. D. Paddock,, T. Morken,, G. L. Campbell,, A. A. Marfin, and, S. R. Zaki. 2004. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum. Pathol. 35:983990.
66. Haley, M.,, A. S. Retter,, D. Fowler,, J. Gea-Banacloche, and, N. P. O’Grady. 2003. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. Clin. Infect. Dis. 37:e88e90. [Online.]
67. Hall, R. A., and, A. A. Khromykh. 2004. West Nile virus vaccines. Exp. Opin. Biol. Ther. 4:12951305.
68. Hamdan, A.,, P. Green,, E. Mendelson,, M. R. Kramer,, S. Pitlik, and, M. Weinberger. 2002. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transplant Infect. Dis. 4:160162.
69. Hassin-Baer, S.,, E. D. Kirson,, L. Shulman,, A. S. Buchman,, H. Bin,, M. Hindiyeh,, L. Markevich, and, E. Mendelson. 2004. Stiff-person syndrome following West Nile fever. Arch. Neurol. 61:938941.
70. Hrnicek, M. J., and, M. E. Mailliard. 2004. Acute West Nile virus in two patients receiving interferon and ribavirin for chronic hepatitis C. Am. J. Gastroenterol. 99:957.
71. Hubalek, Z., and, J. Halouzka. 1999. West Nile fever—a reemerging mosquito-borne viral disease in Europe. Emerg. Infect. Dis. 5:643650.
72. Iwamoto, M.,, D. B. Jernigan,, A. Guasch,, M. J. Trepka,, C. G. Blackmore,, W. C. Hellinger,, S. M. Pham,, S. Zaki,, R. S. Lanciotti,, S. E. Lance-Parker,, C. A. DiazGranados,, A. G. Winquist,, C. A. Perlino,, S. Wiersma,, K. L. Hillyer,, J. L. Goodman,, A. A. Marfin,, M. E. Chamberland, and, L. R. Petersen. 2003. Transmission of West Nile virus from an organ donor to four transplant recipients. N. Engl. J. Med. 348:21962203.
73. Jeha, L. E.,, C. A. Sila,, R. J. Lederman,, R. A. Prayson,, C. M. Isada, and, S. M. Gordon. 2003. West Nile virus infection: a new acute paralytic illness. Neurology 61:5559.
74. Johnson, B. W.,, O. Kosoy,, D. A. Martin,, A. J. Noga,, B. J. Russell,, A. A. Johnson, and, L. R. Petersen. 2005. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis. 5:137145.
75. Jordan, I.,, T. Briese,, N. Fischer,, J. Y. Lau, and, W. I. Lipkin. 2000. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J. Infect. Dis. 182:12141217.
76. Jupp, P. G., 2001. The ecology of West Nile virus in South Africa and the occurrence of outbreaks in humans. Ann. N. Y. Acad. Sci. 951:143152.
77. Kalil, A. C.,, M. P. Devetten,, S. Singh,, B. Lesiak,, D. P. Poage,, K. Bargenquast,, P. Fayad, and, A. G. Freifeld. 2005. Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin. Infect. Dis. 40:764766.
78. Kanagarajan, K.,, S. Ganesh,, M. Alakhras,, E. S. Go,, R. A. Recco, and, M. M. Zaman. 2003. West Nile virus infection presenting as cerebellar ataxia and fever: case report. South. Med. J. 96:600601.
79. Karpati, A. M.,, M. C. Perrin,, T. Matte,, J. Leighton,, J. Schwartz, and, R. G. Barr. 2004. Pesticide spraying for West Nile virus control and emergency department asthma visits in New York City, 2000. Environ. Health Perspect. 112:11831187.
80. Kelley, T. W.,, R. A. Prayson,, A. I. Ruiz,, C. M. Isada, and, S. M. Gordon. 2003. The neuropathology of West Nile virus meningoencephalitis. A report of two cases and review of the literature. Am. J. Clin. Pathol. 119:749753.
81. Khairallah, M.,, S. Ben Yahia,, A. Ladjimi,, H. Zeghidi,, F. Ben Romdhane,, L. Besbes,, S. Zaouali, and, R. Messaoud. 2004. Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology 111:20652070.
82. Khosla, J., 2004. West Nile encephalitis presenting as opsoclonus-myoclonus-cerebellar ataxia. Ann. Neurol. 56:S70.
83. Klee, A. L.,, B. Maidin,, B. Edwin,, I. Poshni,, F. Mostashari,, A. Fine,, M. Layton, and, D. Nash. 2004. Long-term prognosis for clinical West Nile virus infection. Emerg. Infect. Dis. 10:14051411.
84. Kleinman, S.,, S. A. Glynn,, M. Busch,, D. Todd,, L. Powell,, L. Pietrelli,, G. Nemo,, G. Schreiber,, C. Bianco, and, L. Katz. 2005. The 2003 West Nile virus United States epidemic: the America’s Blood Centers experience. Transfusion 45:469479.
85. Kleinschmidt-DeMasters, B. K.,, B. A. Marder,, M. E. Levi,, S. P. Laird,, J. T. McNutt,, E. J. Escott,, G. T. Everson, and, K. L. Tyler. 2004. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch. Neurol. 61:12101220.
86. Komar, N., 2003. West Nile virus: epidemiology and ecology in North America. Adv. Virus Res. 61:185234.
87. Komar, N.,, S. Langevin,, S. Hinten,, N. Nemeth,, E. Edwards,, D. Hettler,, B. Davis,, R. Bowen, and, M. Bunning. 2003. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg. Infect. Dis. 9:311322.
88. Komar, O.,, M. B. Robbins,, K. Klenk,, B. J. Blitvich,, N. L. Marlenee,, K. L. Burkhalter,, D. J. Gubler,, G. Gonzalvez,, C. J. Pena,, A. T. Peterson, and, N. Komar. 2003. West Nile virus transmission in resident birds, Dominican Republic. Emerg. Infect. Dis. 9:12991302.
89. Kulstad, E. B., and, M. D. Wichter. 2003. West Nile encephalitis presenting as a stroke. Ann. Emerg. Med. 41:283.
90. Kumar, D.,, M. A. Drebot,, S. J. Wong,, G. Lim,, H. Artsob,, P. Buck, and, A. Humar. 2004. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am. J. Transplant. 4:18831888.
91. Kumar, D.,, G. V. Prasad,, J. Zaltzman,, G. A. Levy, and, A. Humar. 2004. Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation 77:399402.
92. Lanciotti, R. S.,, J. T. Roehrig,, V. Deubel,, J. Smith,, M. Parker,, K. Steele,, B. Crise,, K. E. Volpe,, M. B. Crabtree,, J. H. Scherret,, R. A. Hall,, J. S. MacKenzie,, C. B. Cropp,, B. Panigrahy,, E. Ostlund,, B. Schmitt,, M. Malkinson,, C. Banet,, J. Weissman,, N. Komar,, H. M. Savage,, W. Stone,, T. McNamara, and, D. J. Gubler. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:23332337.
93. Lanciotti, R. S.,, G. D. Ebel,, V. Deubel,, A. J. Kerst,, S. Murri,, R. Meyer,, M. Bowen,, N. McKinney,, W. E. Morrill,, M. B. Crabtree,, L. D. Kramer, and, J. T. Roehrig. 2002. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology 298:96105.
94. Lefrancois, T.,, B. J. Blitvich,, J. Pradel,, S. Molia,, N. Vachiery,, G. Pallavicini,, N. L. Marlenee,, S. Zientara,, M. Petitclerc, and, D. Martinez. 2005. West Nile virus surveillance, Guadeloupe, 2003–2004. Emerg. Infect. Dis. 11:11001103.
95. Le Guenno, B.,, A. Bougermouh,, T. Azzam, and, R. Bouakaz. 1996. West Nile: a deadly virus? Lancet 348:1315.
96. Lorono-Pino, M. A.,, B. J. Blitvich,, J. A. Farfan-Ale,, F. I. Puerto,, J. M. Blanco,, N. L. Marlenee,, E. P. Rosado-Paredes,, J. E. Garcia-Rejon,, D. J. Gubler,, C. H. Calisher, and, B. J. Beaty. 2003. Serologic evidence of West Nile virus infection in horses, Yucatan State, Mexico. Emerg. Infect. Dis. 9:857859.
97. Marberg, K.,, N. Goldblum,, V. V. Sterk,, W. Jasinska-Klingberg, and, M. A. Klingberg. 1956. The natural history of West Nile fever. I. Clinical observations during an epidemic in Israel. Am. J. Hyg. 64:259269.
98. Marciniak, C.,, S. Sorosky, and, C. Hynes. 2004. Acute flaccid paralysis associated with West Nile virus: motor and functional improvement in 4 patients. Arch. Phys. Med. Rehabil. 85:19331938.
99. Marfin, A. A.,, L. R. Petersen,, M. Eidson,, J. Miller,, J. Hadler,, C. Farello,, B. Werner,, G. L. Campbell,, M. Layton,, P. Smith,, E. Bresnitz,, M. Cartter,, J. Scaletta,, G. Obiri,, M. Bunning,, R. C. Craven,, J. T. Roehrig,, K. G. Julian,, S. R. Hinten,, D. J. Gubler, and, the ArboNET Cooperative Surveillance Group. 2001. Widespread West Nile virus activity, eastern United States, 2000. Emerg. Infect. Dis. 7:730735.
100. Marlenee, N. L.,, M. A. Lorono-Pino,, B. J. Beaty, and, B. J. Blitvich. 2004. Detection of antibodies to West Nile and Saint Louis encephalitis viruses in horses. Salud Publica Mexico 46:373375.
101. Mattar, S.,, E. Edwards,, J. Laguado,, M. Gonzales,, J. Alvarez, and, N. Komar. 2005. West Nile virus antibodies in Colombian horses. Emerg. Infect. Dis. 11:14961497.
102. Minke, J. M.,, L. Siger,, K. Karaca,, L. Austgen,, P. Gordy,, R. Bowen,, R. W. Renshaw,, S. Loosmore,, J. C. Audonnet, and, B. Nordgren. 2004. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch. Virol. Suppl. 18:221230.
103. Mitchell, C. J.,, J. W. Kilpatrick,, R. O. Hayes, and, H. W. Curry. 1970. Effects of ultra-low volume applications of malathion in Hale County, Texas. II. Mosquito populations in treated and untreated areas. J. Med. Entomol. 7:8591.
104. Monath, T. P., 2002. Jennerian vaccination against West Nile virus. Am. J. Trop. Med. Hyg. 66:113114.
105. Montgomery, S. P.,, C. C. Chow,, S. W. Smith,, A. A. Marfin,, D. R. O’Leary, and, G. L. Campbell. 2005. Rhabdomyolysis in patients with west Nile encephalitis and meningitis. Vector Borne Zoonotic Dis. 5:252257.
106. Morrey, J. D.,, C. W. Day,, J. G. Julander,, L. M. Blatt,, D. F. Smee, and, R. W. Sidwell. 2004. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir. Chem. Chemother. 15:101109.
107. Moskowitz, D. W., and, F. E. Johnson. 2004. The central role of angiotensin I-converting enzyme in vertebrate pathophysiology. Curr. Top. Med. Chem. 4:14331454.
108. Mostashari, F.,, M. L. Bunning,, P. T. Kitsutani,, D. A. Singer,, D. Nash,, M. J. Cooper,, N. Katz,, K. A. Lil-jebjelke,, B. J. Biggerstaff,, A. D. Fine,, M. C. Layton,, S. M. Mullin,, A. J. Johnson,, D. A. Martin,, E. B. Hayes, and, G. L. Campbell. 2001. Epidemic West Nile encephalitis, New York, 1999: results of a house hold-based seroepidemiological survey. Lancet 358:261264.
109. Murgue, B.,, S. Murri,, H. Triki,, V. Deubel, and, H. G. Zeller. 2001. West Nile in the Mediterranean basin: 1950–2000. Ann. N. Y. Acad. Sci. 951:117126.
110. Murgue, B.,, H. Zeller, and, V. Deubel. 2002. The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curr. Top. Microbiol. Immunol. 267:195221.
111. Nash, D.,, F. Mostashari,, A. Fine,, J. Miller,, D. O’Leary,, K. Murray,, A. Huang,, A. Rosenberg,, A. Greenberg,, M. Sherman,, S. Wong, and, M. Layton. 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344:18071814.
112. Nir, Y. D., 1959. Airborne West Nile virus infection. Am. J. Trop. Med. Hyg. 8:537539.
113. O’Leary, D. R.,, A. A. Marfin,, S. P. Montgomery,, A. M. Kipp,, J. A. Lehman,, B. J. Biggerstaff,, V. L. Elko,, P. D. Collins,, J. E. Jones, and, G. L. Campbell. 2004. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis. 4:6170.
114. Park, M.,, J. S. Hui, and, R. E. Bartt. 2003. Acute anterior radiculitis associated with West Nile virus infection. J. Neurol. Neurosurg. Psychiatry 74:823825.
115. Pealer, L. N.,, A. A. Marfin,, L. R. Petersen,, R. S. Lanciotti,, P. L. Page,, S. L. Stramer,, M. G. Stobierski,, K. Signs,, B. Newman,, H. Kapoor,, J. L. Goodman, and, M. E. Chamberland. 2003. Transmission of West Nile virus through blood transfusion in the United States in 2002. N. Engl. J. Med. 349:12361245.
116. Pepperell, C.,, N. Rau,, S. Krajden,, R. Kern,, A. Humar,, B. Mederski,, A. Simor,, D. E. Low,, A. McGeer,, T. Mazzulli,, J. Burton,, C. Jaigobin,, M. Fearon,, H. Artsob,, M. A. Drebot,, W. Halliday, and, J. Brunton. 2003. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. Can. Med. Assoc. J. 168:13991405.
117. Perelman, A., and, J. Stern. 1974. Acute pancreatitis in West Nile fever. Am. J. Trop. Med. Hyg. 23:11501152.
118. Petersen, L. R., and, E. B. Hayes. 2004. Westward ho?—the spread of West Nile virus. N. Engl. J. Med. 351:22572259.
119. Petersen, L. R., and, J. S. Epstein. 2005. Problem solved? West Nile virus and transfusion safety. N. Engl. J. Med. 353:516517.
120. Platonov, A. E.,, G. A. Shipulin,, O. Y. Shipulina,, E. N. Tyutyunnik,, T. I. Frolochkina,, R. S. Lanciotti,, S. Yazyshina,, O. V. Platonova,, I. L. Obukhov,, A. N. Zhukov,, Y. Y. Vengerov, and, V. I. Pokrovskii. 2001. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg. Infect. Dis. 7:128132.
121. Pletnev, A. G.,, R. Putnak,, J. Speicher,, E. J. Wagar, and, D. W. Vaughn. 2002. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc. Natl. Acad. Sci. USA 99:30363041.
122. Pletnev, A. G.,, M. S. Claire,, R. Elkins,, J. Speicher,, B. R. Murphy, and, R. M. Chanock. 2003. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology 314:190195.
123. Pogodina, V. V.,, M. P. Frolova,, G. V. Malenko,, G. I. Fokina,, G. V. Koreshkova,, L. L. Kiseleva,, N. G. Bochkova, and, N. M. Ralph. 1983. Study on West Nile virus persistence in monkeys. Arch. Virol. 75:7186.
124. Pyrgos, V., and, F. Younus. 2004. High-dose steroids in the management of acute flaccid paralysis due to West Nile virus infection. Scand. J. Infect. Dis. 36:509512.
125. Quirin, R.,, M. Salas,, S. Zientara,, H. Zeller,, J. Labie,, S. Murri,, T. Lefrancois,, M. Petitclerc, and, D. Martinez. 2004. West Nile virus, Guadeloupe. Emerg. Infect. Dis. 10:706708.
126. Reisen, W. K.,, G. Yoshimura,, W. C. Reeves,, M. M. Milby, and, R. P. Meyer. 1984. The impact of aerial applications of ultra-low volume adulticides on Culex tarsalis populations (Diptera: Culicidae) in Kern County, California, USA, 1982. J. Med. Entomol. 21:573585.
127. Robinson, R. L.,, S. Shahida,, N. Madan,, S. Rao, and, N. Khardori. 2003. Transient parkinsonism in West Nile virus encephalitis. Am. J. Med. 115:252253.
128. Rose, R. I., 2001. Pesticides and public health: integrated methods of mosquito management. Emerg. Infect. Dis. 7:1723.
129. Saad, M.,, S. Youssef,, D. Kirschke,, M. Shubair,, D. Haddadin,, J. Myers, and, J. Moorman. 2005. Acute flaccid paralysis: the spectrum of a newly recognized complication of West Nile virus infection. J. Infect. 51:120127.
130. Sampson, B. A.,, C. Ambrosi,, A. Charlot,, K. Reiber,, J. F. Veress, and, V. Armbrustmacher. 2000. The pathology of human West Nile virus infection. Hum. Pathol. 31:527531.
131. Sayao, A. L.,, O. Suchowersky,, A. Al-Khathaami,, B. Klassen,, N. R. Katz,, R. Sevick,, P. Tilley,, J. Fox, and, D. Patry. 2004. Calgary experience with West Nile virus neurological syndrome during the late summer of 2003. Can. J. Neurol. Sci. 31:194203.
132. Sejvar, J. J.,, M. B. Haddad,, B. C. Tierney,, G. L. Campbell,, A. A. Marfin,, J. A. Van Gerpen,, A. Fleischauer,, A. A. Leis,, D. S. Stokic, and, L. R. Petersen. 2003. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290:511515.
133. Sejvar, J. J.,, A. V. Bode,, A. A. Marfin,, G. L. Campbell,, D. Ewing,, M. Mazowiecki,, P. V. Pavot,, J. Schmitt,, J. Pape,, B. J. Biggerstaff, and, L. R. Petersen. 2005. West Nile virus-associated flaccid paralysis. Emerg. Infect. Dis. 11:10211027.
134. Sherman-Weber, S., and, P. Axelrod. 2004. Central diabetes insipidus complicating West Nile encephalitis. Clin. Infect. Dis. 38:10421043.
135. Shimoni, Z.,, M. J. Niven,, S. Pitlick, and, S. Bulvik. 2001. Treatment of West Nile virus encephalitis with intravenous immunoglobulin. Emerg. Infect. Dis. 7:759.
136. Smithburn, K. C.,, T. P. Hughes,, A. W. Burke, and, J. H. Paul. 1940. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. Hyg. 20:470492.
137. Solomon, T.,, N. M. Dung,, B. Wills,, R. Kneen,, M. Gainsborough,, T. V. Diet,, T. T. Thuy,, H. T. Loan,, V. C. Khanh,, D. W. Vaughn,, N. J. White, and, J. J. Farrar. 2003. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet 361:821826.
138. Southam, C. M., and, A. E. Moore. 1954. Induced virus infections in man by the Egypt isolates of West Nile virus. Am. J. Trop. Med. Hyg. 3:1950.
139. Spigland, I.,, W. Jasinska-Klingberg,, E. Hofshi, and, N. Goldblum. 1958. Clinical and laboratory observations in an outbreak of West Nile fever in Israel in 1957. Harefuah 54:275280.
140. Stramer, S. L.,, C. T. Fang,, G. A. Foster,, A. G. Wagner,, J. P. Brodsky, and, R. Y. Dodd. 2005. West Nile virus among blood donors in the United States, 2003 and 2004. N. Engl. J. Med. 353:451459.
141. Szilak, I., and, G. Y. Minamoto. 2000. West Nile viral encephalitis in an HIV-positive woman in New York. N. Engl. J. Med. 342:5960.
142. Tesh, R. B.,, J. Arroyo,, A. P. Travassos Da Rosa,, H. Guzman,, S. Y. Xiao, and, T. P. Monath. 2002. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg. Infect. Dis. 8:13921397.
143. Tsai, T. F.,, F. Popovici,, C. Cernescu,, G. L. Campbell, and, N. I. Nedelcu. 1998. West Nile encephalitis epidemic in southeastern Romania. Lancet 352:767771.
144. Watson, J. T.,, P. E. Pertel,, R. C. Jones,, A. M. Siston,, W. S. Paul,, C. C. Austin, and, S. I. Gerber. 2004. Clinical characteristics and functional outcomes of West Nile fever. Ann. Intern. Med. 141:360365.
145. Yim, R.,, K. M. Posfay-Barbe,, D. Nolt,, G. Fatula, and, E. R. Wald. 2004. Spectrum of clinical manifestations of West Nile virus infection in children. Pediatrics 114:16731675.
146. Zohrabian, A.,, E. B. Hayes, and, L. R. Petersen. 2006. Cost-effectiveness of West Nile virus vaccination. Emerg. Infect. Dis. 12:375380.

Tables

Generic image for table
Table 1.

Reported numbers of cases of WNV infection, neuroinvasive disease, and death, United States, 1999 to 2005

Citation: Petersen L. 2007. West Nile Virus, p 99-119. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch6
Generic image for table
Table 2.

Symptoms reported among patients with WNV infection by location, year, and hospitalization status

Citation: Petersen L. 2007. West Nile Virus, p 99-119. In Scheld W, Hooper D, Hughes J (ed), Emerging Infections 7. ASM Press, Washington, DC. doi: 10.1128/9781555815585.ch6

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error